Raised $600M in Series C funding, led by Vitruvian Partners.
The company said the funding supports invest in its AI-native technology platform and navigation across hyper-local, condition-specific care.
The AfterRaise week
80 rounds, $6.0B of announced capital. The largest: Angle Health raised $600M. Sorted by size; every figure links to its source.
The company said the funding supports invest in its AI-native technology platform and navigation across hyper-local, condition-specific care.
The company said the funding supports accelerate its growth, deepen its international presence, and expand industrial and technological capabilities.
The announcement did not set out what the funding supports.
The company said the funding supports fuel its next phase of growth, scale its agentic control plane, and expand its security, productivity, and governance capabilities across browsers, endpoints, networks, and data.
The company said the funding supports grow the capacity of its agentic data factory to meet demand and accelerate investment in vertical and enterprise AI.
The company said the funding supports advance ENV-294 and ENV-308 into later-stage trials and additional indications, advance ENV-6946 through mid-phase trials, bring additional medicines into clinical trials for inflammatory and metabolic conditions, and scale PRISM and the automated laboratory that feeds it.
The company said the funding supports expand its clinical program, advance Layer 7™ through the next stages of FDA review, and build the infrastructure needed for commercialization.
The company said the funding supports expand operations and its development efforts.
The company said the funding supports accelerate product development across all layers of its AI cloud, including inference, and multiply its compute capacity over the next year.
The company said the funding supports expand its AI capabilities and the technology that empowering its pharmacy benefits model.
The announcement did not set out what the funding supports.
The company said the funding supports scale globally, invest in R&D, expand into new global markets, build out talent and processes, and launch interactive digital humans.
The announcement did not set out what the funding supports.
The company said the funding supports expand operations and its development efforts.
The company said the funding supports expand its liquid credit facilities and warehouse lending lines, scale its core data science and risk-modeling engineering teams, strengthen automated regulatory compliance frameworks, and accelerate consumer user acquisition across North America.
The company said the funding supports accelerate product development and grow its team across engineering, sales, marketing, and product.
The company said the funding supports expand its research team, conduct frontier atmospheric research and expand operations globally.
The company said the funding supports expand the engineering team, accelerate development of both its software operating system, Go.OS, and hardware line, and scale its go-to-market efforts.
The company said the funding supports scale its go-to-market efforts and continue investing in the platform.
The company said the funding supports the construction and commissioning of Solcoa One, expanded reactor manufacturing in Alameda, and growth of its engineering and research teams.
The company said the funding supports grow its platform for rapid data generation to power frontier intelligence for protein design, as well as advancement of its pipeline of AI-designed therapeutics, including BHB810 and BHB299, to key clinical readouts.
The company said the funding supports expand coverage for its library, Alexandria, deeper indexes and retrieval systems, direct connections to first-party sources, and payment infrastructure that allows knowledge contributors to earn from data used by AI agents.
The company said the funding supports complete its ongoing ATHENA pivotal IDE study, continue product development, and secure global regulatory approvals for its neurovascular portfolio.
The company said the funding supports accelerate product development, expand its presence in food service, and continue growing its product, engineering, and its go-to-market teams.
The company said the funding supports expand operations and its business reach.
The company said the funding supports support its international expansion and accelerate the development of its technology infrastructure and real-world applications.
The company said the funding supports expand engineering investment in its data platform, scale its go-to-market efforts and deepen its enterprise footprint across Amazon Web Services, Microsoft Azure, and Google Cloud.
The company said the funding supports increase production capacity for its Cypris platform, advance product development, expand engineering, commercial, and customer-support teams and build after-sales infrastructure.
The company said the funding supports scale its tokenized capital markets infrastructure, expanding its onchain settlement features, and growing its corporate card-issuance business.
The company said the funding supports expand operations and its business reach.
The company said the funding supports accelerate its expansion, advance multiple infrastructure projects, and invest in tools to evaluate and develop new sites faster through its AI-Accelerated Site Development Platform.
The company said the funding supports accelerate international expansion, expand its presence into the United States with a new office in Boston, deepen product capabilities, and scale deployments with life sciences organisations.
The company said the funding supports support ongoing IND/CTA-enabling activities and advance its lead drug candidate, KTX-0141, through Phase 1/1b clinical trials for major depressive disorder (MDD), with clinical development slated to begin in the second half of 2027.
The company said the funding supports build its Zenith platform, accelerate product development across data and AI, expand its team with 50 new roles, and scale operations across Europe, the Americas, and Asia.
The company said the funding supports expand operations and its development efforts.
The company said the funding supports expand its teams and facilities in the U.S. and Taiwan, as well as scale research and development, operations, sales, and marketing capabilities to qualify, manufacture, and bring its Vertical Cavity Surface Emitting Laser (VCSEL) and optical link products to market.
The company said the funding supports further develop its proprietary legal action model, grow its legal engineering and product teams, and invest further in onboarding technology.
The announcement did not set out what the funding supports.
The announcement did not set out what the funding supports.
The company said the funding supports the commercial expansion in the United States and development of new high-value workflows for the intensive care unit and circulatory support settings, where time-critical imaging decisions directly shape patient management.
The Daily Brief
Every disclosed US, UK and European round of $5M or more, with what each company said the money supports, the morning it is observed. One email, only on days something happened, unsubscribe with one click.